The healthtech capital investor.

Empowering innovation that improves lives

Healthtech Innovators

about us

understand, advise & shape

MTIP is a pan-European healthtech growth capital investor based in Basel, Switzerland. We invest in digital health companies, with offerings that provide clear health-related economic benefits. Our entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with our portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors.


our success stories

MTIP has played — and will continue to play — a vital role in opening doors and creating potential partnerships for Tytocare throughout Europe.
Dedi Gilad
Co-Founder & CEO TytoCare
MTIP’s expertise in digital health and its healthcare industry network are key to our development and expansion into new markets.
Leon Lerman
CEO of Cynerio
We are delighted to partner with MTIP. The new financing has enabled us to rapidly roll out our uniquely effective solution to large patient populations across Europe and to further develop the underlying technology to better address patients’ unmet needs.
Dr. Kai Eberhardt
Co-Founder & CEO Oviva


Trends and insights from our healthtech experts

Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development

The psychology of decision making

What makes a good investor?

Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage

MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!

Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!

MTIP invests in Mediktor

New investment in Mediktor

SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right

MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round

MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia

Private Equity 101: Part one – Glossary

Are you new to the healthtech space?

Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey

Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II

blog blog blog blog blog blog blog blog blog blog

How to pitch to a healthtech Investor

Blog Pitching

MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health

MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020

press press

4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour

MTIP invests in Trialbee

New investment in Trialbee

news news news news news news news news news news news news news

TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round

The digital healthtech sector is expanding – and so are we!

Two new empolyees start in April

MTIP has sucessfully exited Blueprint Genetics

Blueprint exit January 2020

New MTIP investment in Oviva

New investment in Oviva

Whitepaper: A positive prognosis for the future of healthtech

Our first Whitepaper


stay informed!